Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/1995
12/06/1995EP0423318B1 Use of c5-c6 esters for the manufacture of a therapeutic composition for cholesterol gallstone dissolution
12/06/1995CN1112838A Chinese proprietary for curing hepatitis
12/06/1995CN1112837A Health-care adhesive plaster for removing food stagnancy for children and the prepn. method
12/05/1995US5473100 Hydroxamic acid derivative
12/05/1995US5472694 Method for manufacturing tea by treating the leaves of Cyclobalanopsis stenophylla
12/04/1995CA2150517A1 Thieno ¬1,5| benzodiazepine use
12/01/1995CA2150301A1 Oxalylamino-benzofuran-and benzothienyl-derivatives
12/01/1995CA2150300A1 Amino-benzofuryl- and thienyl-derivatives
11/1995
11/30/1995WO1995032218A1 Neurotensin antagonist peptides
11/30/1995WO1995032217A1 Peptide antagonist intermediates of neurotensin
11/30/1995WO1995032209A1 AZABICYCLOALKYL DERIVATIVES OF IMIDAZO(1,5-a)INDOL-3-ONE AS 5HT3 ANTAGONISTS
11/30/1995WO1995032208A1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL(5,1-c)(1,4)BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS
11/30/1995WO1995032204A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
11/30/1995WO1995031991A2 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
11/30/1995WO1995031987A1 Use of pteridine derivatives as no-synthase inhibitors
11/30/1995WO1995031985A2 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
11/30/1995DE4418096A1 Verwendung von Pteridin-Derivaten als Hemmstoffe der NO-Synthase The use of pteridine derivatives as inhibitors of NO synthase
11/30/1995CA2166621A1 Azabicycloalkyl derivatives of imidazo(1,5-a)indol-3-one and process for their preparation
11/30/1995CA2166619A1 Imidazolylalkyl derivatives of imidazo(1,5-a)indol-3-one and their use as therapeutic agents
11/30/1995CA2166617A1 Imidazolylalkyl derivatives of imidazol(5,1-c)(1,4)benzoxazin-1-one and their use as therapeutic agents
11/29/1995EP0683780A1 Imidazopyridines and their use in treating gastrointestinal diseases
11/29/1995EP0683775A1 Heterocyclic 4-aminomethylpiperidine derivatives, their preparation and application in therapy
11/29/1995EP0683767A1 Azacyclic compounds, compositions containing them and their use as tachykinin antagonists
11/29/1995CN1112442A Baicaoshengshou oral liquor and its preparation
11/28/1995US5470983 Preparation of omeprazole and lansoprazole, and intermediates useful therein
11/28/1995US5470948 Vasopressin and vasotocin derivatives
11/28/1995US5470885 Respriatory, gastrointestinal
11/28/1995US5470882 Diphenylsulfide with urea and sulfonates
11/28/1995US5470867 Imidazoles and their salts having antagonistic activity to angiotesin II recetors
11/28/1995US5470865 Pharmaceutical composition
11/28/1995US5470830 Motilin-like polypeptides that inhibit gastrointestinal motor activity
11/28/1995US5470589 Hardening agent for affected tissues of the digestive system
11/28/1995US5470574 Active principle isolated from shark tissue
11/28/1995US5470565 Toothpaste, tooth powder, mouthwash
11/23/1995WO1995031455A1 Quinolinecarboxylic acid derivative
11/23/1995WO1995031197A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2189528A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
11/23/1995CA2167055A1 Quinolinecarboxylic acid derivative
11/22/1995EP0682878A2 Nutrition
11/22/1995EP0682521A1 Method of treating damaged mucosal and epithelial tissues with misoprostol
11/22/1995CN1112122A Sulfated-glycolipid derivatives as cell adhesion inhibitors
11/22/1995CN1112114A Novel aminoalkyl benzoxazolinones and benzothiazolinones process for their preparation and the pharmaceutical compositions which contain them
11/22/1995CN1112112A New bicyclic derivatives of imidazole, their preparation process, the new intermediates obtained, their use as medicaments and the pharmaceutical compositions containing them
11/22/1995CN1112018A Traditional Chinese medicine preparation for prevention and treatment of hepatitis B
11/22/1995CN1111986A Isoxazole derivatives for the treatment of irritable bowels syndrome
11/21/1995US5468773 Treating postmenopausal osteoporosis; side effect reduction
11/21/1995US5468758 5-HT antagonists
11/21/1995US5468744 Composition comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use
11/21/1995US5468494 Polypeptides as anticarcinogenic agents
11/21/1995US5468479 Compositions containing lactic acid bacterium Streptococcus salivarius
11/16/1995WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME
11/16/1995WO1995030746A1 Antisense inhibition of hepatitis c virus
11/16/1995WO1995030687A1 Neurokinine (tachykinine) antagonists
11/16/1995WO1995030675A1 Biphenylcarboxamides useful as 5-ht1d antagonists
11/16/1995WO1995030674A1 Morpholine derivatives and their use as antagonists of tachikinins
11/16/1995WO1995030407A1 Chewable anti-gastric acidity pastilles
11/16/1995WO1995028418A3 Tachykinin antagonists
11/16/1995CA2189764A1 Neurokinine (tachykinine) antagonists
11/16/1995CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same
11/16/1995CA2189141A1 Morpholine derivatives and their use as antagonists of tachikinins
11/15/1995EP0682024A1 Cyclohexane derivatives, processes for their preparation and their use as glucose-6-phosphatase inhibitors
11/15/1995EP0681833A2 Nasally administrable compositions
11/15/1995EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
11/15/1995EP0681571A1 Spiro-substituted azacycles as tachykinin receptor antagonists
11/15/1995EP0681476A1 Unit dose form of bismuth subsalicylate.
11/15/1995EP0238545B1 C20 through c26 amino steroids
11/15/1995CN1111618A Urea-subtituted benzoylguanidines, proces for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/1995CN1111517A Xiebiting medical powder for curing diseases of intestines and stomach and preparation thereof
11/15/1995CN1030252C Tetrahydrobenzimidazole derivative
11/14/1995US5466701 Saccharin derivative proteolytic enzyme inhibitors
11/14/1995CA1337548C Fatty acid composition
11/09/1995WO1995029933A1 Modified milk growth factor
11/09/1995WO1995029694A1 Collagen hydrolysis accelerator
11/09/1995WO1995029682A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWIS?a¿
11/09/1995DE4415999A1 Magensäurebindende Kaupastillen Gastric acid binding Kaupa breastfeeding
11/09/1995CA2189013A1 Binding of e-selectin, p-selectin or l-selectin to sialyl-lewisx or sialyl-lewisa
11/08/1995EP0680488A1 2,6-diaminopurine derivatives
11/08/1995EP0680334A1 Morphogen treatment of gastrointestinal ulcers
11/08/1995EP0539448B1 Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
11/08/1995CN1111239A Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkycarboxylates and intermediates
11/07/1995US5464815 Extending plasma half-life of selectin by coadministering with compound which inhibits binding of selectin to low affinity heparin-like site on surface of cells of organ perfused with blood; assaying sensitivity; pharmaceutical composition
11/07/1995CA2063872C Pharmaceutical preparation based on plasma proteins
11/02/1995WO1995029194A1 Peptides as therapeutic agents for the treatment of auto-immune diseases
11/02/1995WO1995029176A1 Substituted 1,3-oxathiolanes with antiviral properties
11/02/1995WO1995029159A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
11/02/1995WO1995029152A1 Benzamide derivatives as vasopressin antagonists
11/02/1995WO1995028943A1 USE OF SPIRAMYCIN FOR TREATING GASTROINTESTINAL DISORDERS CAUSED BY $i(H. PYLORI)
11/02/1995WO1995028931A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679403A1 Preventive and remedy for allergic disease
11/02/1995EP0679194A1 Method to predict active growth of bacteria adhered to a surface
11/02/1995EP0679189A1 Cloning of enterokinase and method of use
11/02/1995EP0679161A1 Thiazolidine derivatives, preparation thereof and drugs containing same
11/02/1995EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/02/1995EP0679092A1 Cytokine restraining agents
11/02/1995DE4413938A1 Peptide als Therapeutikum für Autoimmunerkrankungen Peptides as therapeutics for autoimmune diseases
11/02/1995CA2188697A1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori
11/02/1995CA2188031A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995CA2187932A1 Substituted sulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
11/01/1995CN1110968A Substituted N-piperidino-pyrazole-3-carboxamide
1 ... 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 ... 1258